Can Cortisol Levels be Used as a Biomarker in Cancer?
There is ongoing research into the potential of using cortisol levels as a biomarker in cancer. Elevated cortisol levels have been observed in patients with various types of cancer, including breast, lung, and ovarian cancers. Monitoring cortisol levels could potentially help in assessing the stress levels and overall health of cancer patients, as well as in tailoring individualized treatment plans. However, more research is needed to establish standardized protocols for using cortisol as a reliable biomarker.
